Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

High materiality9/10

Teladoc's Mixed Q1 Results Lead to Post-Earnings Stock Decline

Apr 29, 2026, 5:16 PM EDT2 sourcesAI-analyzed

Why it may matterVerify against the original reporting

The stock's decline post-earnings highlights investor discontent with the company's mixed results and profitability miss, reminiscent of similar instances in tech stock reactions to earnings.

AI summary

What happened, with direct paths to the underlying reporting

Teladoc Health's Q1 results showed mixed revenue trends, with Integrated Care performing solidly while BetterHelp struggled. The stock dropped 5.6% to $5.62 in after-hours trading, reflecting investor concerns about its profitability amid ongoing strategic investments. Revised guidance may not reassure investors ahead of Q2 earnings.

Teladoc reported Q1 revenue of $613.8M, down 2% YoY.
Missed EPS estimate with a loss of 36 cents per share.
Integrated Care revenue rose 2% YoY; BetterHelp fell 9% YoY.
Guiding Q2 revenue of $597-$626M, near consensus of $623.67M.
Stock fell 5.6% to $5.62 in after-hours trading.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.